Aceso Life Science Group Limited (0474.HK) HKSE
0.11
+0.001(+0.92%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.11
+0.001(+0.92%)
Currency In HKD
| Market Cap | 367.05M |
| Enterprise Value | 2.54B |
| P/E Ratio | -2.17 |
| PEG Ratio | 0.14 |
| Price/Sales Ratio | 4.93 |
| Price/Book Ratio | 2.17 |
| Enterprise/Revenue | 11.2 |
| Enterprise/EBITDA | -8.85 |
| Fiscal Year | March 31, 2025 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -2.24 |
| Operating Margin | -0.32 |
| Return On Assets | -0.22 |
| Return On Equity | -1.94 |
| Revenue | 195M |
| Revenue/Share | 0.02 |
| Gross Profit | 90M |
| EBITDA | -860M |
| Net Income | -895M |
| Diluted EPS | -0.12 |
| Total Cash | 330M |
| Total Cash/Share | 0.05 |
| Total Debt | 1.23B |
| Total Debt/Equity | 3.31 |
| Current Ratio | 3.2 |
| Book Value Per Share | 0.05 |
| 52-Week Change | 511.11 |
| 52-Week High | 0.14 |
| 52-Week Low | 0.02 |
| Moving Average 50 Days | 0.12 |
| Moving Average 200 Days | 0.1 |
| Average Volume | 1.08M |
| Shares Outstanding | 7.44B |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 7:6 |
| Last Split Date | July 12, 2017 |